- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05509686
The Immediate Effects of Intermittent Theta Burst Stimulation on Intracortical Excitability of the Primary Motor Cortex in Patients With Chronic Stroke
The Immediate Effects of Intermittent Theta Burst Stimulation on Intracortical Excitability of the Primary Motor Cortex in Patients With Chronic Stroke: A Concurrent TMS-EEG Sham-controlled Crossover Study
Study Overview
Status
Conditions
Detailed Description
The neurophysiological effect of intermittent theta burst stimulation (iTBS) has been examined with TMS-electromyography (EMG)-based outcomes in healthy people; however, its effects in intracortical excitability and inhibition are largely unknown in patients with stroke. Concurrent transcranial magnetic stimulation and electroencephalogram (TMS-EEG) recording can be used to investigate both intracortical excitatory and inhibitory circuits of the primary motor cortex (M1) and the property of brain networks.
This study is to investigate the immediate effects of iTBS on intracortical excitatory and inhibitory circuits, neural connectivity, and network properties in patients with chronic stroke, using TMS-EEG and TMS-EMG approaches.
In this randomized, sham-controlled, crossover study, 21 patients with chronic stroke receive two separate stimulation conditions: a single-session iTBS or sham stimulation applied to the ipsilesional M1, in two separate visits, with a washout period of five to seven days between the two visits after crossover. A battery of TMS-EMG and TMS-EEG measurements are taken before and immediately after stimulation during the visit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong, 000000
- Kenneth FONG
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- suffered from first-ever, ischemic or hemorrhagic, unilateral stroke, verified by neuroimaging examinations such as CT or MRI.
- detectable motor evoked potentials from the affected first dorsal interosseous muscle;
- provided written informed consent.
Exclusion Criteria:
- had any contraindication to transcranial magnetic stimulation;
- had a known neurological disease excluding stroke, or psychiatric disease;
- were using a psychostimulant, sedative, antidepressant, or antiepileptic medication.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: A single-session intermittent theta burst stimulation (iTBS)
The classical 600-pulse iTBS protocol is delivered to the motor hotspot over the ipsilesional hemisphere.
|
A single-session standard 600-pulse intermittent theta burst stimulation (iTBS) is applied to the ipsilesional primary motor cortex.
|
SHAM_COMPARATOR: A single-session sham intermittent theta burst stimulation (iTBS)
The sham stimulation is the same as that of iTBS, but the coil is placed five centimeters away from the scalp.
|
The sham stimulation is the same as that of iTBS, but the coil is placed five centimeters away from the scalp.
Electrical field simulation shows that the setups for sham stimulation would not induce any valid cortical activation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Transcranial magnetic stimulation-evoked potential
Time Frame: Baseline (before iTBS stimulation)
|
Single pulses evoked an initial response in electroencephalogram, followed by a series of time- and phase-locked positive and negative deflections which could spread to the connected brain areas.
The evoked potential is called transcranial magnetic stimulation-evoked potential.
|
Baseline (before iTBS stimulation)
|
Transcranial magnetic stimulation-evoked potential
Time Frame: 10 minutes after a single-session iTBS stimulation
|
Single pulses evoked an initial response in electroencephalogram, followed by a series of time- and phase-locked positive and negative deflections which could spread to the connected brain areas.
The evoked potential is called transcranial magnetic stimulation-evoked potential.
|
10 minutes after a single-session iTBS stimulation
|
Motor evoked potential (MEP)
Time Frame: Baseline (before iTBS stimulation)
|
Single TMS pulses with suprathreshold intensity (120% of resting motor threshold of the stimulated cortex) applied to the primary motor cortex (M1) can produce recordable MEPs in contralateral muscles; additionally, the peak-to-peak amplitude of MEPs can be used to represent the corticospinal excitability
|
Baseline (before iTBS stimulation)
|
Motor evoked potential (MEP)
Time Frame: 10 minutes after a single-session iTBS stimulation
|
Single TMS pulses with suprathreshold intensity (120% of resting motor threshold of the stimulated cortex) applied to the primary motor cortex (M1) can produce recordable MEPs in contralateral muscles; additionally, the peak-to-peak amplitude of MEPs can be used to represent the corticospinal excitability
|
10 minutes after a single-session iTBS stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cortical silent period
Time Frame: Baseline (before iTBS stimulation)
|
The cortical silent period (cSP) is a protocol measuring the intracortical inhibition, in which suprathreshold test pulses (120% of resting motor threshold of the stimulated cortex) are applied to the contralateral M1, while participants sustain 30% maximum voluntary contraction.
Specifically, cSP refers to the interruption of background electromyographic (EMG) activity after the TMS pulse.
|
Baseline (before iTBS stimulation)
|
Cortical silent period
Time Frame: 10 minutes after a single-session iTBS stimulation
|
The cortical silent period (cSP) is a protocol measuring the intracortical inhibition, in which suprathreshold test pulses (120% of resting motor threshold of the stimulated cortex) are applied to the contralateral M1, while participants sustain 30% maximum voluntary contraction.
Specifically, cSP refers to the interruption of background electromyographic (EMG) activity after the TMS pulse.
|
10 minutes after a single-session iTBS stimulation
|
Short-interval intracortical inhibition
Time Frame: Baseline (before iTBS stimulation)
|
Short-interval intracortical inhibition (SICI) is a form of paired-pulse protocol, in which a subthreshold conditioning pulse is delivered 2 ms before a suprathreshold test pulse.
Theoretically, the amplitude of motor-evoked potentials (MEPs) evoked by a test pulse at a given intensity is suppressed compared with that evoked by a single pulse at the same intensity.
Eight trials are recorded, with inter-trial intervals ranging from 4 s to 5 s.
The intensity of test pulses is fixed at 120% of the resting motor threshold, and the intensity of the conditioning pulse is set at 80% of the resting motor threshold.
The result of SICI is expressed as the ratio of a paired-pulse MEP amplitude to a single-pulse MEP amplitude.
|
Baseline (before iTBS stimulation)
|
Short-interval intracortical inhibition
Time Frame: 10 minutes after a single-session iTBS stimulation
|
Short-interval intracortical inhibition (SICI) is a form of paired-pulse protocol, in which a subthreshold conditioning pulse is delivered 2 ms before a suprathreshold test pulse.
Theoretically, the amplitude of motor-evoked potentials (MEPs) evoked by a test pulse at a given intensity is suppressed compared with that evoked by a single pulse at the same intensity.
Eight trials are recorded, with inter-trial intervals ranging from 4 s to 5 s.
The intensity of test pulses is fixed at 120% of the resting motor threshold, and the intensity of the conditioning pulse is set at 80% of the resting motor threshold.
The result of SICI is expressed as the ratio of a paired-pulse MEP amplitude to a single-pulse MEP amplitude.
|
10 minutes after a single-session iTBS stimulation
|
Intracortical facilitation
Time Frame: Baseline (before iTBS stimulation)
|
The setups for the intensity of intracortical facilitation (ICF) are almost the same as those for SICI; however, the interstimulus interval is longer, 10 ms.
Eight trials are recorded, with inter-trial intervals ranging from 4 s to 5 s.
The intensity of test pulses is fixed at 120% of the resting motor threshold, and the intensity of the conditioning pulse is set at 80% of the resting motor threshold.
The result of ICF is expressed as the ratio of a paired-pulse MEP amplitude to a single-pulse MEP amplitude.
|
Baseline (before iTBS stimulation)
|
Intracortical facilitation
Time Frame: 10 minutes after a single-session iTBS stimulation
|
The setups for the intensity of intracortical facilitation (ICF) are almost the same as those for SICI; however, the interstimulus interval is longer, 10 ms.
Eight trials are recorded, with inter-trial intervals ranging from 4 s to 5 s.
The intensity of test pulses is fixed at 120% of the resting motor threshold, and the intensity of the conditioning pulse is set at 80% of the resting motor threshold.
The result of ICF is expressed as the ratio of a paired-pulse MEP amplitude to a single-pulse MEP amplitude.
|
10 minutes after a single-session iTBS stimulation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kenneth Fong, PhD, Hong Kong Polytechnic University, QT517, Hung Hom
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSEARS20200621001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Intermittent theta burst stimulation (iTBS)
-
University of NottinghamRecruitingFeasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS (TMS4MS)Multiple Sclerosis | Cognitive ImpairmentUnited Kingdom
-
VA Office of Research and DevelopmentNot yet recruitingSuicidal Ideation | Mild Traumatic Brain Injury | ImpulsivityUnited States
-
University of California, Los AngelesTerminated
-
King's College LondonSouth London and Maudsley NHS Foundation TrustWithdrawnBinge-Eating DisorderUnited Kingdom
-
Fabio FerrarelliNational Institute of Mental Health (NIMH)RecruitingSchizophreniaUnited States
-
Vastra Gotaland RegionUppsala University; Göteborg University; The Gothenburg Society of MedicineRecruiting
-
Stanford UniversityEnrolling by invitationTreatment Resistant DepressionUnited States
-
Jean-Marie AnnoniCompleted
-
Chang Gung Memorial HospitalUnknown
-
Hôpital le VinatierTerminated